Global Travel Vaccines Market By Overview
Travel Vaccines Market are the first step towards healthy and smart travel. Travel vaccines provide immunization by decreasing the risk of getting sick while travelling abroad. Different countries have different diseases prevailing or existing within the region. Such as tourists travelling to South America and central countries of Africa must get vaccinated for Yellow Fever. Health organizations mainly recommend travel vaccines which are especially to tourists who travel to developing or endemic countries. For example, DUKORAL is a travel vaccine that protects tourists from Cholera and Diarrhea. These are some common diseases caused by drinking contaminated water and intake of food while travelling. Travel vaccine shot recommendations vary from person to person depending on age, gender, and medical history of the tourist.
Global Travel Vaccines Market By Drivers & Restraints
Growth in global travel and migration is one of the significant factors driving the growth of the global travel vaccines market. Migration by sea, air, and land have resulted in the spread of disease-causing vectors and pathogens. Additionally, the increasing contact of people with different animals and plants has also resulted in the movement of pathogens to people. This inspires vaccine manufacturers to invest in research and development activities to come up with advanced, new, and effective vaccines which will, in turn, propel the global market’s growth opportunities over the forecast period. Moreover, there are also incidences based on travel-related diseases growing. There is a growth in the prevalence of travel-related diseases such as typhoid, Hepatitis A & E, tetanus, cholera, diphtheria, Japanese encephalitis, meningitis, yellow fever globally. This will further increase investments towards the development of more operative vaccines, augmenting the growth scenarios of the target market. However, new vaccines are usually more expensive and travel clinics offer vaccinations at a slightly higher price.
Global Travel Vaccines Market By Segmentations & Regional Insights
The global travel vaccines market is segmented based on composition, disease, and region.
Based on composition, the global travel vaccines market is segmented into mono vaccines and combination vaccines. Based on disease, the target market is classified into hepatitis A, DPT, yellow fever, typhoid, hepatitis b, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others.
Regional Insights:
On the region, the global travel vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2017, North America was the highest revenue contributing region for the target market and is projected to continue to dominate the market over the forecast period. The U.S was one of the largest revenue contributors in the region, capturing a substantial portion of the target market. Also, the growing demand for vaccines that deals to meet the unmet medical needs provides an opportunity for sellers to develop new efficient and safe molecules, which will boost the growth of this market in the region.
Global Travel Vaccines Market, By Composition:
- Mono Vaccines
- Combination Vaccines
Global Travel Vaccines Market, By Vaccine Type:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Global Travel Vaccines Market, By Region:
- North America
-
-
- North America Travel Vaccines Market, By Composition
- North America Travel Vaccines Market, By Vaccine Type
- North America Travel Vaccines Market, By Country
- U.S.
- Canada
- Europe
- Europe Travel Vaccines Market, By Composition
- Europe Travel Vaccines Market, By Vaccine Type
- Europe Travel Vaccines Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Asia Pacific Travel Vaccines Market, By Composition
- Asia Pacific Travel Vaccines Market, By Vaccine Type
- Asia Pacific Travel Vaccines Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Latin America Travel Vaccines Market, By Composition
- Latin America Travel Vaccines Market, By Vaccine Type
- Latin America Travel Vaccines Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Middle East & Africa Travel Vaccines Market, By Composition
- Middle East & Africa Travel Vaccines Market, By Vaccine Type
- Middle East & Africa Travel Vaccines Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
-
Global Travel Vaccines Market By Competitive Landscape & Key Players
The key players operating the global Travel Vaccines market include GlaxoSmithKline Pharmaceuticals Limited, Merck & Co., Inc., Sanofi Pasteur, Novartis AG, CSL Limited, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), AstraZeneca PLC, and Altimmune, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the Compositions to gain a competitive edge in the target market. For instance, In October 2019, GlaxoSmithKline Pharmaceuticals Limited has sold off two travel vaccines to Bavarian Nordic. As the company shifts its focus away from drugs it acquired through a multi-billion “asset swap” deal with Novartis a few years ago.
Global Travel Vaccines Market By Company Profile
- GlaxoSmithKline Pharmaceuticals Limited
-
-
- Company Overview
- Product Portfolio
-
-
-
-
-
- Key Highlights
- Financial Performance
- Business Strategies
-
-
- Merck & Co., Inc.
- Sanofi Pasteur
- Novartis AG
- CSL Limited
- Pfizer Inc.
- ALK-Abelló A/S
- Bavarian Nordic A/S
- Crucell (Subsidiary of Johnson & Johnson)
- AstraZeneca PLC
- Altimmune, Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Travel Vaccines Market By Highlights
FAQs
The travel vaccines market is segmented based on composition, disease, and region.
the development of vaccines for emerging diseases, the increasing focus on traveler health and safety, and advancements in vaccine technologies tailored for specific destinations, presenting significant opportunities in the global Travel Vaccines Market.
the growing international travel, the rising awareness of travel-related health risks, government initiatives for immunization before travel, and the need to prevent the spread of infectious diseases across borders.
North America, Europe, and Asia-Pacific are likely to be key regions, with the dominance influenced by travel volumes and healthcare infrastructure.
The key players operating the global Travel Vaccines market include GlaxoSmithKline Pharmaceuticals Limited, Merck & Co., Inc., Sanofi Pasteur, Novartis AG, CSL Limited, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), AstraZeneca PLC, and Altimmune, Inc.